This page includes the latest FDA filings for Novartis Consumer Health. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
Device Company | Device | Date |
---|---|---|
Endo USA, Inc. | Prescription Medication | 2024-10-30 |
Endo USA, Inc. | Prescription Medication | 2024-07-09 |
Endo USA, Inc. | Prescription Medication | 2022-07-14 |
Endo USA, Inc. | Prescription Medication | 2020-08-13 |
Endo Pharmaceuticals Inc., Novartis Consumer Health, Par Pharmaceutical Inc. | Prescription Medication | 2019-11-02 |
Endo Pharmaceuticals Inc., Novartis Consumer Health, Par Pharmaceutical Inc. | Prescription Medication | 2019-10-29 |
Endo Pharmaceuticals Inc., Novartis Consumer Health, Par Pharmaceutical Inc. | Prescription Medication | 2019-10-10 |
Endo Pharmaceuticals Inc., Novartis Consumer Health, Par Pharmaceutical Inc. | Prescription Medication | 2019-07-30 |
Endo USA, Inc. | Prescription Medication | 2019-03-05 |
Novartis Consumer Health, | Theraflu ExpressMax | 2015-07-15 |
Novartis Consumer Health, | Theraflu ExpressMax | 2015-07-15 |
Novartis Consumer Health | Meijer NICOTINE TRANSDERMAL SYSTEM | 2007-11-05 |
Novartis Consumer Health | Meijer NICOTINE TRANSDERMAL SYSTEM | 2007-11-05 |
Novartis Consumer Health | Meijer NICOTINE TRANSDERMAL SYSTEM | 2007-11-05 |
Novartis Consumer Health, | Theraflu | 2005-05-13 |
NCAGE Code | U6015 | NOVARTIS CONSUMER HEALTH |
NCAGE Code | B0386 | NOVARTIS CONSUMER HEALTH |
CAGE Code | B0386 | NOVARTIS CONSUMER HEALTH |
CAGE Code | U6015 | NOVARTIS CONSUMER HEALTH |